Estrella Immunopharma Inc. (ESLA) Stock Analysis

Estrella Immunopharma Inc. (ESLA) is a publicly traded company in the HEALTHCARE sector. It trades at $1.12, carries a market capitalization of $48.20M. This page summarizes the public market data, fundamentals, and frequently asked questions for ESLA, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $1.12
• Market Cap: $48.20M
• EPS: $-0.34
• 52-Week High: $3.15
• 52-Week Low: $0.78

Market Sentiment

Estrella Immunopharma Inc. currently has a Neutral sentiment score of -0.06.

About Estrella Immunopharma Inc.

Estrella Immunopharma, Inc. is a preclinical-stage biopharmaceutical company based in Emeryville, California, focused on pioneering T-cell therapies aimed at treating blood cancers and solid tumors. With a strong commitment to advancing innovative immunotherapy solutions, Estrella seeks to address critical unmet medical needs in oncology. The company’s cutting-edge research and development efforts position it as a key player in the evolving landscape of cancer treatment, with an emphasis on h...

GNG Research Analysis

GNG Research scores Estrella Immunopharma Inc. (ESLA) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for ESLA.

Frequently Asked Questions

Does ESLA pay dividends?

Estrella Immunopharma Inc. (ESLA) does not currently pay a regular dividend.

What is ESLA's market cap?

Estrella Immunopharma Inc. (ESLA) has a market capitalization of $48.20M with a current stock price of $1.12.